Tirzepatide – Dual-Incretin Research Peptide | 15mg

Tirzepatide – Dual-Incretin Research Peptide | 15mg Lyophilized Powder | RUO Grade | BlueBiotech® Research Supply

GLP-1 + GIP Receptor Agonist for Metabolic & Weight Loss Research | Made in USA | Research Use Only

Tirzepatide is a novel dual-incretin peptide that mimics both GLP-1 and GIP activity, currently being researched for its impact on metabolic disorders, weight loss pathways, and insulin signaling. Supplied as 5mg RUO-grade lyophilized powder per vial. Manufactured in the USA by BlueBiotech® under high-purity conditions. For Research Use Only – Not for human use.

Field Name	Example Value
Product Name	Tirzepatide – Dual-Incretin Research Peptide \| 5mg Lyophilized Powder \| RUO Grade \| BlueBiotech® Research Supply
Product Code	PPT-HK-15-880011
Product Type	Research Peptide
Category	Peptides / Weight Management / Metabolic Research
Manufacturer	BlueBiotech® Research Facility
Appearance	White lyophilized powder
Dosage / Units	5mg per vial
Purity	≥99% (HPLC)
Quantity Options	5mg / 10mg / 15mg
Storage	Store at -20°C; protect from light
Shelf Life	24 months unopened
Packaging	Sterile 10R vial, vacuum-sealed with RUO labeling
Manufacturer Origin	USA – Made in USA
Use Classification	RUO – Research Use Only (Not for human consumption, diagnostic, or therapeutic use)
Tags	tirzepatide, GLP-1 agonist, GIP analog, weight loss peptide, dual incretin, BlueBiotech, metabolic research, RUO, made in USA

⚠️This product is labeled for Research Use Only (RUO). Not for human or veterinary therapeutic use.
See RUO Declaration for more info.

Tirzepatide | Research Peptide

Category: Peptides → Weight Management / Metabolic Research
CAS No.: 2023788-19-2
Molecular Formula: C₂₂₅H₃₄₃N₆₅O₇₀
Sequence: [Synthetic 39-amino acid peptide]

Scientific Overview

Tirzepatide is a novel dual agonist of GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors, developed for its potential in metabolic disorder research, particularly obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). Its unique unimolecular peptide structure enhances glucose-dependent insulin secretion while promoting significant body weight reduction through central appetite modulation and delayed gastric emptying.

Tirzepatide has attracted considerable attention in academic and clinical circles due to its superior efficacy compared to GLP-1 receptor agonists alone (e.g., semaglutide), as demonstrated in large-scale randomized trials.

Key Mechanisms Under Investigation

Dual receptor activity: GIP and GLP-1
Improved glycemic control via β-cell stimulation
Weight reduction via appetite suppression and delayed gastric emptying
Modulation of lipid metabolism and systemic inflammation markers

Highlighted Research Studies

SURPASS-1 to SURPASS-5 Clinical Trials Series
Efficacy and safety of Tirzepatide in adults with T2DM
JAMA, 2021–2022
→ Demonstrates HbA1c reduction up to 2.3% and weight loss up to 11.2 kg
Integrated Mechanistic Analysis
Dual GIP and GLP-1 receptor agonism and metabolic outcomes
Nature Reviews Endocrinology, 2022
→ Explores molecular signaling pathways responsible for metabolic benefits
Comparative Efficacy vs. Semaglutide
Tirzepatide vs Semaglutide once weekly in T2DM patients (SURPASS-2)
NEJM, 2021
→ Tirzepatide demonstrated statistically superior outcomes on both glycemic and weight endpoints
Early Preclinical Studies
GIPR/GLP1R co-agonism enhances insulinotropic and weight loss effects in murine models
Cell Metabolism, 2018

For Research Use Only

This product is intended for laboratory research purposes only. It is not for human consumption, nor for medical, diagnostic, or therapeutic use. All customers must comply with local regulations regarding importation and handling of research peptides.

Also in GLP-1 Peptides:

Corporate Advantages

High-Purity Standards

Tested for purity and identity. COAs available
for all RUO compounds

Buyer Protection

Protected and discrete fulfillment
available upon request

Research-Grade Support

Dedicated service for labs, clinics, and
compounders handling RUO items.

Lab-Grade Quality Assurance

All compounds are tested for-identity and purity, COAs and supporting documentation are available upon request.

Strict RUO Compliance

All products are labeled for Researd Use Only (RUO), Not intended for human or veterinary therapeutic or diagnostic purposes.

Lab-Grade Quality Assurance

Custom branding.
white-label optionons and formulation assistancee available for eligible research institutions and partners.

Custom R&D & APl Synthesis

We support original
pharmaceutica solutions.custom research projects, and NDC-grade materials-meeting speifica.tions for qualified partners.

Serving Professionals Across the U.S.& Mexico

Trusted by MedSpas, wellness clinics and licensed compounders under licensed compounding relationships.

Secure & Discreet Fulfillment

Cold-chain shipping : private, plain.wrap packaging, and tracking for sensitive RUO materials.

⚠️ All compounds are provided strictly for Research Use Only (RUO). BLUEBIOTECH does not endorse or support clinical, therapeutic, or diagnostic use of its products unless under licensed compounder supervision.

Tirzepatide – Dual-Incretin Research Peptide | 15mg